Conference icon

Conference

Cardiac safety of fingolimod 0.5 mg during the first-dose observation in a 4-month, open-label, multicentre FIRST study in relapsing multiple sclerosis patients

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience
Role:
Author
Expand authors...
Volume:
259
Pages:
S69-S69
Publication date:
2012-06-05
ISSN:
0340-5354
URN:
uuid:ca1645fa-5ae6-4e2f-8271-2a8fb11a74df
Source identifiers:
346217
Local pid:
pubs:346217

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP